Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.

Oral minoxidil proven safe, effective for treating alopecia

29 Jun 2020

Use of low-dose oral minoxidil is safe and effective in the treatment of androgenic alopecia (AGA) and alopecia areata (AA), in addition to demonstrating a big advantage over the topical formulation in terms of convenience and patient compliance, as reported in a systematic review.

Researchers searched multiple electronic databases for relevant studies and identified 10 articles for the final review, of which four were prospective studies, three were retrospective studies, and three were case reports. The total study population included 19,218 patients with alopecia (98.9 percent male).

Low-dose oral minoxidil therapy was used for a variety of alopecic types including male and female AGA in four studies (n=19,079), AA in two studies (n=99), chronic telogen effluvium (CTE) in one study (n=36), monilethrix in one study (n=2), chemotherapy-induced alopecia (CIA) in one study (n=1), and loose anagen hair syndrome (LAHS) in one study (n=1). Dose ranged from 0.25 to 5 mg daily and twice daily.

The strongest evidence existed for AGA and AA, with 61–100 percent and 18–82.4 percent of patients in the respective groups demonstrating objective clinical improvement. The drug also proved successful in treating female pattern hair loss, chronic telogen effluvium, monilethrix, and permanent chemotherapy‐induced alopecia.

The most common adverse effects were hypertrichosis and postural hypotension.

With regard to the clinical decision of choosing between oral and topical therapy, a recent editorial outlined the five C’s of oral minoxidil: convenience, cosmesis, cost-savings, co-therapy, and compliance. The oral route of administration would factor in patients with severe hair loss with a surface area too large for topical coverage alone, multiple topical regimens used, or difficult synchronization with bathing and activity schedules. Furthermore, treatment compliance might be more readily achieved with a daily systemic medication vs topical therapy. [Dermatol Ther 2018;31:e12707]

Finally, oral minoxidil has proved valuable in treating complicated, refractory cases of alopecia, inducing clinically significant hair regrowth in patients who failed first-line therapy. [Australas J Dermatol 2018;59:e286-e287]

Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.